Imidazole derivatives as cholesterol-lowering agents

International Journal of Cardiology

Volumn 90, Issue 2-3, 2003, Pages 145-146

  Wierzbicki, Anthony S ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

ACAT; Cholesterol; Ketoconazole; Lipid lowering; Metronidazole

Indexed keywords

EZETIMIBE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; KETOCONAZOLE; METRONIDAZOLE; TAK 275; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CHOLESTEROL SYNTHESIS; EDITORIAL; ENZYME INHIBITION; HUMAN; LIPID METABOLISM; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0041883323     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00561-2     Document Type: Editorial

References (10)

1. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-64.
2. Buchwald H., Campos C.T. Program on the surgical control of the hyperlipidemias: 1994 report. J. Cardiovasc. Pharmacol. 25:(Suppl. 4):1995;S3-10.
3. Brown W.V. Novel approaches to lipid lowering: what is on the horizon? Am. J. Cardiol. 87:2001;23B-27B.
4. Ahmed S., Smith J.H., Nicholls P.J., Whomsley R., Cariuk P. Synthesis and biological evaluation of imidazole based compounds as cytochrome P-450 inhibitors. Drug Des. Discov. 13:1995;27-41.
5. Elokdah H., Sulkowski T., Cochran D., McKean M.L., Quinet F. Effects of 2- (substituted-sulfanyl)-3,5-dihydro-imidazole-4-one and 2- (substituted-sulfanyl)-1H-imidazole-4,5-dione derivatives on serum HDL-cholesterol. Bioorg. Med.Chem. Lett. 10:2000;1791-1794.
6. Kraemer F.B., Spilman S.D. Effects of ketoconazole on cholesterol synthesis. J. Pharmacol. Exp.Ther. 238:1986;905-911.
7. Stalenhoef A.F., Stuyt P.M., de Graaf J. Effects of ketoconazole on plasma lipids and lipoprotein(a) in familial hypercholesterolaemia, compared with simvastatin. Neth. J. Med. 51:1997;10-15.
8. Astles P.C., Ashton M.J., Bridge A.W., Harris N.V., Hart T.W., Parrott D.P., et al. Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT. J. Med. Chem. 39:1996;1423-1432.
9. Burnett J.R., Wilcox L.J., Huff M.W. Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion. Clin. Chim. Acta. 286:1999;231-242.
10. Kempen H.J., van Son K., Cohen L.H., Griffioen M., Verboom H., Havekes L. Effect of ketoconazole on cholesterol synthesis and on HMG-CoA reductase and LDL-receptor activities in Hep G2 cells. Biochem. Pharmacol. 36:1987;1245-1249.